Clinical Trials in Texas

Showing 12721-12740 of 12,973 trials

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

NCT00327223

AMP-011 is a Phase 1 study designed to extend the understanding of the toxicity and pharmacology of imexon by investigating a schedule of daily treatment for 5 days every three weeks. The objective of the study is to determine the maximally tolerated dose, the pharmacokinetics, and the toxicity of the drug on the designated schedule.

Neoplasm Metastasis

AmpliMed Corporation18 participantsStarted Nov 2005

Indianapolis, Indiana, United States • Albany, New York, United States • Temple, Texas, United States +1 more locations

COMPLETEDNA55 miles

A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port

NCT00486109

This study investigated wearability and usability of the I-PORT™ Injection Port (I-PORT™), a new disposable injection port through which prescribed medication is injected subcutaneously from a standard syringe or pen. Additional investigation compared subject opinion towards using the I-PORT™ device compared to standard injection therapy.

Type 1 DiabetesType 2 Diabetes

Patton Medical Devices74 participantsStarted Oct 2006

Atlanta, Georgia, United States • Omaha, Nebraska, United States • Austin, Texas, United States +2 more locations

COMPLETEDPhase 2116 miles

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

NCT00642499

The primary purpose of this study is to determine if dronabinol is effective in preventing or treating nausea caused by HAART (highly active anti-retroviral therapy) in HIV and AIDS patients

Highly Active Antiretroviral Therapy (HAART)-Related Nausea and VomitingHIV Infections

Solvay Pharmaceuticals103 participantsStarted Aug 2003

Bakersfield, California, United States • Fresno, California, United States • Los Angeles, California, United States +33 more locations

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Find Trials by Condition in Texas

Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

The Atrial High Rate Episodes in Pacemaker Patients

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

GALLANT 4 Tesaglitazar vs. Glibenclamide